EICHOR

Recruiting studies: Primary Immunodeficiency Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency
Phase 3 · 1 location(s) · On Pharma Importadora, Exportadora e Distribuidora de Medica · NCT06954441 Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Phase 2 · 2 location(s) · National Cancer Institute (NCI) · NCT02579967 Pathogenic Study of Adult Immune Enteropathies
Phase N/A · 4 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04280510 EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
Phase 2 · 8 location(s) · New York Medical College · NCT03266653 Studies of Disorders With Increased Susceptibility to Fungal Infections
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01222741 NIAID Centralized Sequencing Protocol
Phase N/A · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT03206099 A Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema
NA · 1 location(s) · Takeda · NCT07293364 Natural History of Bronchiectasis
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00943514 Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06169150 Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failu
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT04232085 Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies
Phase N/A · 1 location(s) · University Children's Hospital, Zurich · NCT02735824 Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in
Phase 3 · 62 location(s) · Pharvaris Netherlands B.V. · NCT06679881 An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
Phase 1/Phase 2 · 3 location(s) · Beijing Tide Pharmaceutical Co., Ltd · NCT07371663 COVID-19 in PID Survey
Phase N/A · 1 location(s) · Imagine Institute · NCT04459689 The Mechanistic Biology of Primary Immunodeficiency Disorders
Phase N/A · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT03394053 Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therap
Phase N/A · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT04160455 TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic D
Phase 2 · 1 location(s) · Johns Hopkins All Children's Hospital · NCT04414046 Study of Chediak-Higashi Syndrome
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT00005917 A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Phase 3 · 42 location(s) · Takeda · NCT06980480 Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation
Phase 2 · 4 location(s) · Pharming Technologies B.V. · NCT06990529 The Experience of Screening for SCID
Phase N/A · 1 location(s) · King's College London · NCT05651113 Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Phase 1/Phase 2 · 4 location(s) · David Williams · NCT03311503 Investigation of the Effects of Pulmonary Rehabilitation in Children With Primary Immunodeficiency
NA · 1 location(s) · Gazi University · NCT06092528 Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Phase 2 · 1 location(s) · Paul Szabolcs · NCT01962415 Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodefic
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01306019 Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00006150 Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06659588 Metabolic Profiling of Immune Responses in Immune-mediated Diseases
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04864886 Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases
Phase N/A · 1 location(s) · Hadassah Medical Organization · NCT00874783 STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · 51 location(s) · ADARx Pharmaceuticals, Inc. · NCT06960213

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →